Ancillary Costs for Donated COVID-19 Vaccine Doses Procured via Bilateral Agreements

This project aims to decrease COVID-19 related mortality and morbidity especially for those experiencing marginalization or vulnerability including women. The project also seeks to provide sufficient vaccine doses to immunize healthcare workers and most vulnerable groups in low- and lower-middle income countries. Project activity includes providing the necessary ancillaries to accompany COVID-19 vaccines declared surplus and donated by Canada to the COVAX Facility. Ancillaries may include freight equipment No-Fault Compensation Scheme contribution safety boxes and syringes.

The expected outcomes of this project include: (1) decreased COVID-19 related mortality and morbidity of populations especially for those experiencing marginalization or vulnerability including women; and (2) increased provision of vaccine doses to support immunization of healthcare workers and most vulnerable groups in low- and lower-middle-income countries.